The board of Directors of ClouDr Group Limited announced that the Company has recently entered into a non-legally binding strategic cooperation agreement with Hong Kong Magicure Medical Co. Ltd. Pursuant to the Agreement, based on their respective strengths, the two parties will carry out multi-dimensional cooperation on cross-border accessibility of innovative medicines and devices for patients in Mainland China, specifically in the fields of oncology, rare diseases, OTC medicines as well as food for special medical purposes. The two parties will adopt a patient-centric approach to address the needs of critical illness management and chronic disease management, so as to enable Mainland China patients to gain access to high-quality, efficient and internationally-advanced medical and healthcare resources.

The strategic cooperation with Hong Kong Magicure Medical will enable the Company to connect the supply chain and accelerate the pace to tie internationally-advanced medical resources with domestic healthcare needs to provide patients with more convenient cross-border interconnected and sharing services regarding medicines and devices, with a view to effectively reducing the burden of medication on patients and enabling more patients to benefit from the services.